Fresenius SE & Co. KGaA (0OO9)
LSE
Closed
Aug 24, 2026
Day's Range
46.0452 wk Range
35.13Overview - 0OO9 - Fresenius SE & Co. KGaA
Key Statistics
Valuation
Enterprise Value
51.19B
P/E (Trailing)
‪25.71‬
PEG Ratio
‪1.49‬
Price / Sales (TTM)
‪0.73‬
Price / Book
‪1.30‬
EV / EBITDA
‪10.95‬
Profitability
Gross Margin
‪26.07%‬
Profit Margin
‪2.40%‬
Operating Margin
‪7.08%‬
Return on Assets
‪2.42%‬
Return on Equity
‪4.98%‬
Ownership
Shares Outstanding
563.23M
Float
410.99M
Held by Insiders
‪26.95%‬
Held by Institutions
‪36.52%‬
Price stats
Beta
‪1.06‬
50-Day Avg
‪43.06‬
200-Day Avg
‪44.89‬
Dividends
Payout Ratio
‪51.69%‬
Frequency
Annual
Market Cap - 0OO9 - Fresenius SE & Co. KGaA
Peers - 0OO9 - Fresenius SE & Co. KGaA
Peer Comparison
Compared with companies in Medical Care Facilities listed on LSE.
Profile Summary - 0OO9 - Fresenius SE & Co. KGaA
About
Fresenius SE & Co. KGaA is a global healthcare group founded in 1912 and headquartered in Bad Homburg, Germany. It specializes in providing critical products and services for treating and caring for critically and chronically ill patients, focusing on therapies like dialysis, infusion, and clinical nutrition. The…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
